|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Depot medroxyprogesterone. Management of side-effects commonly associated |
| with its contraceptive use. |
| Archer B; Irwin D; Jensen K; Johnson ME; Rorie J |
| JOURNAL OF NURSE-MIDWIFERY. 1997 Mar-Apr;42(2):104-11. |
| In this clinical practice exchange, nurse-midwives in a variety of settings and US regions describe their treatment |
| strategies for addressing the side effects associated with depot medroxyprogesterone acetate (DMPA). Although |
| DMPA is a safe, effective, long-acting method of hormonal contraception, this injectable has been linked with side |
| effects such as weight gain, menstrual changes, headache, dizziness, acne, abdominal bloating, breast swelling, |
| depression, reduced libido, and alopecia. Approximately one-third of DMPA acceptors discontinue use by the end of |
| the first year and half discontinue by the end of the second year, primarily because of these side effects. Nurse- |
| midwives report that adolescents who are unable to take the pill consistently and breast-feeding women are ideal |
| candidates for DMPA use. Constant vaginal bleeding, the most troublesome side effect, can be treated through use |
| of ibuprofen, oral estrogen, or oral DMPA. Potential or actual weight gain can be averted through life-style changes |
| such as reduced dietary fats and increased exercise. Unanticipated pregnancies can be avoided by administering |
| the initial DMPA injection within 5 days after the onset of menses. Pre-acceptance anticipatory counseling, along |
| with regular support and encouragement, increase user satisfaction with DMPA. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Depot medroxyprogesterone. Management of side-effects |
| commonly associated with its contraceptive use.", is(are) Archer B; Irwin D; Jensen K; Johnson ME; Rorie J. The |
| source of this article is "JOURNAL OF NURSE-MIDWIFERY. 1997 Mar-Apr;42(2):104-11.". This article was published |
| in 1997 in English language(s). (PubHealth.info® Document ID: CONT2T 543-06. All rights reserved with |
| PubHealth.info) PIN: 5543 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |